Fact Check: Dementia is characterized by a decline in cognitive function.

Fact Check: Dementia is characterized by a decline in cognitive function.

Published July 2, 2025
VERDICT
True

# Fact Check: "Dementia is characterized by a decline in cognitive function." ## What We Know Dementia is defined as a syndrome that leads to a decli...

Fact Check: "Dementia is characterized by a decline in cognitive function."

What We Know

Dementia is defined as a syndrome that leads to a decline in cognitive function, which includes memory, thinking, behavior, communication, judgment, and the ability to perform daily activities. The World Health Organization (WHO) states that this decline is beyond what is expected from the usual consequences of aging. While dementia can affect individuals of any age, it is most prevalent among those aged 65 and older. Importantly, aging itself does not equate to dementia, as dementia is not considered a normal part of aging (Department of Health and Aged Care).

The WHO further elaborates that dementia encompasses various types, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, among others. Each type can present different symptoms, but the overarching characteristic is the decline in cognitive abilities (Department of Health and Aged Care, WHO).

Analysis

The claim that "dementia is characterized by a decline in cognitive function" is supported by multiple credible sources. The WHO, a leading authority on health matters, explicitly defines dementia as a condition marked by cognitive decline that significantly impacts daily functioning (WHO). This definition aligns with the information provided by the Australian Department of Health, which emphasizes that dementia affects cognitive abilities and daily activities (Department of Health and Aged Care).

Both sources are reliable and authoritative, as they are produced by governmental health organizations and the WHO, which are recognized for their expertise in public health. The definitions provided are consistent and reflect a consensus in the medical community regarding the nature of dementia.

Furthermore, the National Dementia Support Program highlights the importance of understanding dementia as a cognitive condition, reinforcing the idea that cognitive decline is a primary characteristic of dementia (National Dementia Support Program).

Conclusion

Verdict: True
The claim that "dementia is characterized by a decline in cognitive function" is accurate and well-supported by authoritative sources. Both the WHO and the Australian Department of Health provide clear definitions that align with this claim, emphasizing that dementia involves significant cognitive decline affecting various aspects of daily life.

Sources

  1. About dementia - Department of Health and Aged Care
  2. National Dementia Support Program (NDSP) - Department of …
  3. Diagnosis, management and support - Department of Health and …
  4. Dementia - World Health Organization (WHO)
  5. Dementia - World Health Organization (WHO)
  6. 痴呆症 - World Health Organization (WHO)
  7. Dementia - World Health Organization (WHO)
  8. Demencia - World Health Organization (WHO)

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
100% Free
No Registration
Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: Dementia is a condition that affects cognitive function and memory.
True
🎯 Similar

Fact Check: Dementia is a condition that affects cognitive function and memory.

Detailed fact-check analysis of: Dementia is a condition that affects cognitive function and memory.

Jul 3, 2025
Read more →
Fact Check: Dementia affects cognitive function and memory.
True
🎯 Similar

Fact Check: Dementia affects cognitive function and memory.

Detailed fact-check analysis of: Dementia affects cognitive function and memory.

Jul 2, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: Donald Trump is experiencing severe cognitive decline and dementia.
Partially True

Fact Check: Donald Trump is experiencing severe cognitive decline and dementia.

Detailed fact-check analysis of: Donald Trump is experiencing severe cognitive decline and dementia.

Jul 11, 2025
Read more →
Fact Check: Dementia is a progressive neurological disease affecting memory and cognitive function.
Unverified

Fact Check: Dementia is a progressive neurological disease affecting memory and cognitive function.

Detailed fact-check analysis of: Dementia is a progressive neurological disease affecting memory and cognitive function.

Jul 2, 2025
Read more →